JDRF Official Statement on Final Regulation Eliminating Current System of Drug Rebates in Medicare Part D
November 24, 2020
November 24, 2020
NEW YORK, Nov. 24 -- JDRF, a charitable 501(c)(3) organization dedicated to funding type 1 diabetes research, issued the following statement:
No one should suffer or die because they cannot afford insulin - that is unacceptable. JDRF has long advocated for affordable insulin, urging manufacturers, health plans, employers, and policymakers to ensure that people with T1D can obtain the lifesaving medication they need at low and predictable out-of-pocket costs.
As part of . . .
No one should suffer or die because they cannot afford insulin - that is unacceptable. JDRF has long advocated for affordable insulin, urging manufacturers, health plans, employers, and policymakers to ensure that people with T1D can obtain the lifesaving medication they need at low and predictable out-of-pocket costs.
As part of . . .